What does PHARMACIE AELBRECHT do?

PHARMACIE AELBRECHT is a pharmacy in Braine-le-Comte. Private Limited, started on 24 February 2009, 1 establishment.

What is the address of PHARMACIE AELBRECHT?

The registered office of PHARMACIE AELBRECHT is located at Rue de la Station 22, 7090 Braine-le-Comte.

Is PHARMACIE AELBRECHT still active?

Yes. According to the CBE (31 October 2026) PHARMACIE AELBRECHT is active, legal situation “Normale toestand”, started on 24 February 2009.

Is PHARMACIE AELBRECHT registered on Peppol?

Yes, PHARMACIE AELBRECHT is registered on the Peppol network with ID 0208:0810007507.

What is the enterprise number of PHARMACIE AELBRECHT?

The enterprise number of PHARMACIE AELBRECHT is BE0810007507.

When was PHARMACIE AELBRECHT founded?

PHARMACIE AELBRECHT was founded on 24 February 2009.

Who are the directors of PHARMACIE AELBRECHT?

According to the 2025 annual accounts, the directors of PHARMACIE AELBRECHT are: JOHAN AELBRECHT .

Is PHARMACIE AELBRECHT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 February 2009; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE AELBRECHT make in 2025?

PHARMACIE AELBRECHT recorded a loss after taxes of € 38,931 in financial year 2025.

What is the revenue of PHARMACIE AELBRECHT?

As a small company, PHARMACIE AELBRECHT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 196,981.

How much does an employee at PHARMACIE AELBRECHT earn?

The average wage cost per full-time employee at PHARMACIE AELBRECHT was € 69,300 in 2022: staff costs of € 90,066 for 1.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

PHARMACIE AELBRECHT (Private Limited) - Braine-le-Comte

Dossier PHARMACIE AELBRECHT, printed on 1 November 2026 from databakkes.be/en/0810007507/pharmacie-aelbrecht. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 54 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACIE AELBRECHT from Braine-le-Comte, company number BE0810007507, closed financial year 2025 with a result of € -38,931 after tax. For that financial year PHARMACIE AELBRECHT recorded a gross margin of € 196,981 and equity of € 62,823. Compared with financial year 2024, the result moved from € -14,452 to € -38,931. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 10, 2026.

What it is worth Healthy

€ 62,823

▼ 38% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -38,931

▼ 169 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 36,722

▼ 19% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 37,823.

People and assets in 2025

Wage cost

€ 101,178

▲ 2% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 32,552

▼ 22% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 10 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 715,252

▲ 143% vs 2024

€ 73,147 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.

Owed to suppliers

€ 88,116

▲ 18% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 17,816

▲ 47% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 227,307 Gross margin 2022: € 227,307 First fiscal year in the series	€ 212,846 Gross margin 2023: € 212,846 ▼ 6% vs 2022 (€ 227,307) Unfavourable step	€ 201,301 Gross margin 2024: € 201,301 ▼ 5% vs 2023 (€ 212,846) Unfavourable step	€ 196,981 Gross margin 2025: € 196,981 ▼ 2% vs 2024 (€ 201,301) Unfavourable step	▼ 2%
Profit after taxes	€ 41,884 Profit after taxes 2022: € 41,884 First fiscal year in the series	€ 16,836 Profit after taxes 2023: € 16,836 ▼ 60% vs 2022 (€ 41,884) Unfavourable step	€ -14,452 Profit after taxes 2024: € -14,452 ▼ € 31,288 vs 2023 (€ 16,836) Unfavourable step	€ -38,931 Profit after taxes 2025: € -38,931 ▼ € 24,478 vs 2024 (€ -14,452) Unfavourable step	▼ € 24,478
Equity	€ 99,370 Equity 2022: € 99,370 First fiscal year in the series	€ 116,205 Equity 2023: € 116,205 ▲ 17% vs 2022 (€ 99,370) Favourable step	€ 101,753 Equity 2024: € 101,753 ▼ 12% vs 2023 (€ 116,205) Unfavourable step	€ 62,823 Equity 2025: € 62,823 ▼ 38% vs 2024 (€ 101,753) Unfavourable step	▼ 38%
Total debts	€ 381,336 Total debts 2022: € 381,336 First fiscal year in the series	€ 466,407 Total debts 2023: € 466,407 ▲ 22% vs 2022 (€ 381,336) Unfavourable step	€ 454,942 Total debts 2024: € 454,942 ▼ 2% vs 2023 (€ 466,407) Favourable step	€ 884,148 Total debts 2025: € 884,148 ▲ 94% vs 2024 (€ 454,942) Unfavourable step	▲ 94%
Cash	€ 91,823 Cash 2022: € 91,823 First fiscal year in the series	€ 47,874 Cash 2023: € 47,874 ▼ 48% vs 2022 (€ 91,823) Unfavourable step	€ 45,502 Cash 2024: € 45,502 ▼ 5% vs 2023 (€ 47,874) Unfavourable step	€ 36,722 Cash 2025: € 36,722 ▼ 19% vs 2024 (€ 45,502) Unfavourable step	▼ 19%
Land & buildings	€ 86,331 Land & buildings 2022: € 86,331 First fiscal year in the series	€ 200,578 Land & buildings 2023: € 200,578 ▲ 132% vs 2022 (€ 86,331) Unchanged	€ 183,576 Land & buildings 2024: € 183,576 ▼ 8% vs 2023 (€ 200,578) Unchanged	€ 166,574 Land & buildings 2025: € 166,574 ▼ 9% vs 2024 (€ 183,576) Unchanged	▼ 9%
Retained profit	€ 74,370 Retained profit 2022: € 74,370 First fiscal year in the series	€ 91,205 Retained profit 2023: € 91,205 ▲ 23% vs 2022 (€ 74,370) Favourable step	€ 76,753 Retained profit 2024: € 76,753 ▼ 16% vs 2023 (€ 91,205) Unfavourable step	€ 37,823 Retained profit 2025: € 37,823 ▼ 51% vs 2024 (€ 76,753) Unfavourable step	▼ 51%
Bank debt	€ 221,414 Bank debt 2022: € 221,414 First fiscal year in the series	€ 290,535 Bank debt 2023: € 290,535 ▲ 31% vs 2022 (€ 221,414) Unfavourable step	€ 294,062 Bank debt 2024: € 294,062 ▲ 1% vs 2023 (€ 290,535) Unfavourable step	€ 715,252 Bank debt 2025: € 715,252 ▲ 143% vs 2024 (€ 294,062) Unfavourable step	▲ 143%
Balance sheet total	€ 480,706 Balance sheet total 2022: € 480,706 First fiscal year in the series	€ 582,612 Balance sheet total 2023: € 582,612 ▲ 21% vs 2022 (€ 480,706) Unchanged	€ 556,695 Balance sheet total 2024: € 556,695 ▼ 4% vs 2023 (€ 582,612) Unchanged	€ 946,971 Balance sheet total 2025: € 946,971 ▲ 70% vs 2024 (€ 556,695) Unchanged	▲ 70%
Employees (FTE)	1.3 Employees (FTE) 2022: 1.3 First fiscal year in the series	-	-	-

Key figures of PHARMACIE AELBRECHT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE AELBRECHT?

What happened at PHARMACIE AELBRECHT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 10, 2026 New annual accounts for financial year 2025: loss of € 38,931. filed late Source: NBB ↗
Feb 27, 2009 New establishment in Braine-le-Comte. KBO
Feb 24, 2009 Start of the company according to the CBE. KBO
2009 JOHAN AELBRECHT became a director. NBB

In short

From € 41,884 profit in 2022 to € 38,931 loss in 2025.

Paid € 41,132 in corporate taxes since 2022.

Best year ever: 2022, with € 41,884 profit.

On average € 174,900 of value added per employee in 2022.

Original PDFs at the National Bank ↗

Management

JOHAN AELBRECHT

PHARMACIE AELBRECHT

Pharmacie Croquet Fiasse 100%

Behind PHARMACIE AELBRECHT is JOHAN AELBRECHT . It owns 100% of Pharmacie Croquet Fiasse itself.

Directors

According to the 2025 annual accounts

JOHAN AELBRECHT

Director

since 2009

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Station 22

7090 Braine-le-Comte

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

ASSOCIATION DES COPROPRIETAIRES DE L IMMEUBLE A BRAINE LE COMTE RUE DE LA STATION 22

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0810.007.507

VAT number

BE 0810.007.507

Registered office

Rue de la Station 22, 7090 Braine-le-Comte

Names & denominations

PHARMACIE AELBRECHT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

24 February 2009

Peppol

Active · Active since 11 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Activiteiten van hoofdkantoren

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE AELBRECHT

Warning lights

Financials

What happened to PHARMACIE AELBRECHT?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions